Skip to main content

MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

29 May 2023 Evaluate
The sales figure stood at Rs. 303.51 millions for the March 2023 quarter. The mentioned figure indicates a growth of about 47.00% as compared to Rs. 206.47 millions during the year-ago period.Modest increase of 11.77% in the Net Profit was reported from. 35.27 millions to Rs. 39.42  millions.Operating Profit saw a handsome growth to 55.84 millions from 49.76 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 303.51 206.47 47.00 1081.38 1012.92 6.76 1081.38 1012.92 6.76
Other Income 1.83 10.71 -82.91 66.04 27.48 140.32 66.04 27.48 140.32
PBIDT 55.84 49.76 12.22 234.26 200.10 17.07 234.26 200.10 17.07
Interest 2.27 0.21 980.95 4.59 0.61 652.46 4.59 0.61 652.46
PBDT 53.57 49.55 8.11 229.67 199.49 15.13 229.67 199.49 15.13
Depreciation 2.70 0.78 246.15 5.15 2.50 106.00 5.15 2.50 106.00
PBT 50.87 48.77 4.31 224.52 196.99 13.98 224.52 196.99 13.98
TAX 11.45 13.50 -15.19 62.29 50.32 23.79 62.29 50.32 23.79
Deferred Tax 10.66 0.07 15128.57 10.62 0.32 3218.75 10.62 0.32 3218.75
PAT 39.42 35.27 11.77 162.23 146.67 10.61 162.23 146.67 10.61
Equity 101.81 100.00 1.81 101.81 100.00 1.81 101.81 100.00 1.81
PBIDTM(%) 18.40 24.10 -23.66 21.66 19.75 9.66 21.66 19.75 9.66
Peers
Company Name CMP
Redington 349.60
Adani Enterprises 2682.00
Amrapali Industries 32.78
Maxgrow India 174.80
Rashi Peripheral 689.15
View more..